Guangzhou Baiyunshan Pharmaceutical Holdings Co (SHSE:600332) FFO


SHSE:600332 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd SHSE:600332
67 GF Score
Price ¥20.04
GF Value ¥29.36
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co FFO?

FFO (Funds from operations) only applies to REITs.

SHSE:600332
67GF Score
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd SHSE:600332
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Guangzhou Baiyunshan Pharmaceutical Holdings Co (SHSE:600332) Overvalued in 2026?

Based on GuruFocus' analysis, Guangzhou Baiyunshan Pharmaceutical Holdings Co stock appears to be undervalued. The current stock price of ¥20.04 is trading 31.7% below its estimated GF Value™ of ¥29.36. GuruFocus considers Guangzhou Baiyunshan Pharmaceutical Holdings Co to be Significantly Undervalued.

Key valuation signals for SHSE:600332:

  • FFO:
  • GF Value™: ¥29.36 vs. price of ¥20.04 (31.7% below fair value)
  • GF Score™: 67/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600332 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Guangzhou Baiyunshan Pharmaceutical Holdings Co Business Description

Other Exchanges 00874:Hong KongGU5:Germany
Address 45 Sha Mian North Street, Liwan District, Guangdong Province, Guangzhou, CHN, 510130
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is engaged in the pharmaceutical and healthcare industry, focusing on the development of a full industrial chain covering research, manufacturing, and distribution. The group operates through five reportable segments. The Modern Chinese Medicine segment involves the R&D, manufacturing, and sale of proprietary Chinese and natural medicines. The Chemical Pharmaceutical Technology segment focuses on chemical drugs, APIs, and intermediates. The Natural Beverages segment produces and sells health-oriented beverage products. The Pharmaceutical Commerce segment is engaged in the wholesale, retail, and import/export of medicines and medical devices. The Other Segments include biotechnology innovation, consumer health, and medical services.
67GF Score

Get the complete analysis for SHSE:600332

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥20.04
Price
¥29.36
GF Value